Insider Trading History of Horvath Susan

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Horvath Susan since 2006. This trader's CIK number is 1322846. At the time of last reporting, Horvath Susan was the V.P. of Finance & CFO of Panbela Therapeutics, Inc.. (stock ticker symbol PBLA). Also see all insider trading activities at Panbela Therapeutics, Inc..

Note that in the past Horvath Susan also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Panbela Therapeutics, Inc. (PBLA) by Horvath Susan

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 PBLA 4,444 $0 0 $0 0 $0
2020 PBLA 4,924 $0 0 $0 0 $0
2019 PBLA 1,428 $0 0 $0 0 $0

Yearly summary of insider trading at Cns Inc /de/ (CNXS) by Horvath Susan

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2006 CNXS 0 $0 1,100 $29,689 34,000 $315,291


Insider trading activities at 2 companies by Horvath Susan:

1. Panbela Therapeutics, Inc. (PBLA)

2. Cns Inc /de/ (CNXS)

Table 1. Insider trading of Panbela Therapeutics, Inc. (PBLA) by Horvath Susan

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-01-30 PBLA Buy 4,444 .00 0
2020-09-01 SNBP Buy 2,424 .00 0
2020-06-05 SNBP Buy 2,500 .00 0
2019-08-30 SNBP Buy 1,428 .00 0

Table 2. Insider trading of Cns Inc /de/ (CNXS) by Horvath Susan

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2006-12-19 CNXS Option Ex 7,600 12.90 98,040
2006-12-12 CNXS Option Ex 5,600 12.39 69,384
2006-08-24 CNXS Sale 1,100 26.99 29,689
2006-01-30 CNXS Option Ex 20,800 7.11 147,867

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Horvath Susan (V.P. of Finance & CFO of Panbela Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.